Tripeptide-10 citrulline: complete guide

Tripeptide-10 citrulline (Decorinyl) is a cosmetic peptide modeled on decorin, a collagen-binding protein. This guide covers its structure, research and status.

Complete guide5 min read

Key takeaway

PubChem lists tripeptide-10 citrulline at 530.6 g/mol, sold under the trade name Decorinyl. Its design paper reported thinner, more uniform collagen fibres in a test-tube assay. The one controlled human study we found had 24 volunteers split into four groups.

At a glance

Article typeComplete guide
Regulatory statusCosmetic / topical“Tripeptide-10 citrulline is a cosmetic ingredient, not an FDA-approved drug.” (this article)
ClassSkin & cosmetic
Body systemsSkin & connective tissue
Studies cited4 in this article · 4 across 1 article on Tripeptide-10 citrulline
Related productsCopper peptides and melanocortin fragments

Tripeptide-10 citrulline is a cosmetic peptide designed to mimic part of decorin, a skin protein that binds collagen. Despite the “tripeptide” in its name, it contains four amino acids. This guide covers its structure, design, research and regulatory status. Sources were checked on November 17, 2026.

Quick answer: Tripeptide-10 citrulline is a synthetic peptide of lysine, aspartic acid, isoleucine and citrulline. It was built from decorin’s collagen-binding sequences to influence how collagen fibres form. CosIng lists it as a skin conditioning ingredient. Evidence is limited to lab work and one small trial.

Vitrapep does not sell tripeptide-10 citrulline; this page is a reference summary of published research and regulatory information.

What is tripeptide-10 citrulline?

The INCI name reads in two parts. CosIng defines the ingredient as “the reaction product of Citrulline and Tripeptide-10.” It adds that tripeptide-10 is a synthetic tripeptide of aspartic acid, isoleucine and lysine (CosIng, 2026). Citrulline is then attached as a fourth amino acid. CosIng names it 5-ureido-2-aminopentanoic acid.

PubChem lists the formula C22H42N8O7 and a molecular weight of 530.6 g/mol (PubChem CID 90479646). In PubChem’s structure, the chain runs lysine, aspartic acid, isoleucine, then citrulline with an amide at the end. That makes it a tetrapeptide, and its developers call it one. Our guide to types of peptides explains these size classes.

PubChem lists Decorinyl as a synonym. The 2008 design paper came from Lipotec SA, of Barcelona, Spain (Puig et al., 2008). A 2020 review also states that Lipotec markets it as Decorinyl (Errante et al., 2020).

Table 1

Tripeptide-10 citrulline: key facts

Fact Detail
INCI name Tripeptide-10 Citrulline
Structure type Linear tetrapeptide with a C-terminal amide; no fatty acid group
Sequence Lys-Asp-Ile-Cit-NH2 (as drawn in PubChem)
Molecular formula C22H42N8O7
Molecular weight 530.6 g/mol
Main cosmetic function (CosIng) Skin conditioning
Trade name(s) Decorinyl

How does tripeptide-10 citrulline work?

The design starts with decorin. Puig and colleagues describe decorin as a protein that binds collagen and helps regulate fibrillogenesis, the assembly of collagen into fibres. They identified two tetrapeptide sequences as decorin’s collagen-binding sites. They then built new tetrapeptides from those sequences, aiming for stronger binding and decorin-like activity (Puig et al., 2008).

The authors framed it as a substitute for functional decorin, which they say declines with age. In their view, it targets collagen quality and fibre organization rather than the amount of collagen made. The 2020 review repeats this: it says the peptide regulates collagen fibre diameter without affecting synthesis (Errante et al., 2020).

That review groups tripeptide-10 citrulline with “signal peptides,” which it describes as able to modulate skin protein turnover. The same review places palmitoyl tripeptide-1 and palmitoyl hexapeptide-12 in that class.

What is tripeptide-10 citrulline used for?

CosIng lists one function: skin conditioning. The ingredient appears in cosmetic formulas under its INCI name or the trade name Decorinyl.

Under US law, intended use decides whether a product is a cosmetic or a drug. A product intended to affect the structure or function of the body can be a drug, even if sold as a cosmetic (FDA, 2024).

What does the research show?

Design study (in vitro). Lipotec scientists screened a focused library of decorin-like tetrapeptides. Tripeptide-10 citrulline gave the best results in a collagen fibrillogenesis assay, a test-tube model of fibre formation. It produced thinner, more uniform fibres. The abstract gives no numbers and reports no cell, tissue or human work (Puig et al., 2008).

Randomized study (human). Researchers in Athens randomized 24 healthy volunteers into four groups over 60 days. Groups received tripeptide-10 citrulline with acetyl hexapeptide-3, either peptide alone, or neither. Skin microtopography was measured with a Visioscan, and water loss through the skin with a Tewameter (Raikou et al., 2017).

The authors reported several significant differences between groups at days 20, 40 and 60. They concluded they had “provided clinical evidence” for an antiwrinkle effect of tripeptide-10 citrulline, and possibly for lower water loss. They also said the study did not clarify how the two peptides might act together. With 24 people across four groups, the trial is small. Acetyl hexapeptide-3 is covered in our Argireline guide.

We found no other peer-reviewed human study of tripeptide-10 citrulline.

What safety data exist?

We found no Cosmetic Ingredient Review (CIR) safety assessment of tripeptide-10 citrulline in searches of cir-safety.org. CosIng lists no EU restrictions and no SCCS opinion for it. The Raikou abstract does not report adverse events.

Under US law, the responsibility sits with companies. FDA states that “Companies and individuals who manufacture or market cosmetics have a responsibility to ensure the safety of their products” (FDA, 2026). The same page notes that neither the law nor FDA rules require specific safety tests for individual ingredients.

Industry scientists have proposed computer screening of peptide sequences for toxin and allergen matches. Their 2026 framework did not test tripeptide-10 citrulline (Bjerke et al., 2026).

What is tripeptide-10 citrulline’s regulatory status, and how is it used in research?

In the United States, cosmetic products and ingredients, other than color additives, need no FDA approval before sale (FDA, 2025). Tripeptide-10 citrulline is a cosmetic ingredient, not an FDA-approved drug.

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) became law on December 29, 2022. It added facility registration, product listing, serious adverse event reporting, safety substantiation records and mandatory recalls (FDA Voices, 2026). In the EU, CosIng lists the ingredient with an active status.

In research, the peptide is a worked example of biomimetic design: copying a protein’s binding site in a short sequence. The Raikou trial also used it to test peptide combinations. For the wider class, see peptides in skincare.

Frequently asked questions about tripeptide-10 citrulline

Is tripeptide-10 citrulline a tripeptide?

Not structurally. It is tripeptide-10 plus citrulline, so it has four amino acids. Its developers call it a tetrapeptide.

What is Decorinyl?

Decorinyl is the trade name. PubChem lists it as a synonym of tripeptide-10 citrulline.

What is decorin?

Decorin is a protein that binds collagen and helps regulate how collagen fibres form, as described in the 2008 design paper.

Has CIR reviewed tripeptide-10 citrulline?

We found no CIR safety assessment of this ingredient.

Is tripeptide-10 citrulline approved by the FDA?

No. FDA does not approve cosmetic ingredients, other than color additives, before they go on the market.

What to know now

  • Structure: Lys-Asp-Ile-Cit-NH2; C22H42N8O7; 530.6 g/mol.
  • Name: four amino acids despite “tripeptide”; trade name Decorinyl.
  • Design: modeled on decorin’s collagen-binding sequences.
  • Evidence: one in vitro design study and one 24-person randomized trial.
  • Safety: no CIR assessment found; no EU restrictions listed.
  • Status: a cosmetic ingredient, not an FDA-approved drug.

What we’re watching

FDA rules under MoCRA. The MoCRA page, updated October 29, 2026, lists good manufacturing practice and fragrance allergen labeling rules that the law requires. Related guides: pentapeptide-18 and Matrixyl.

More for skin & connective tissue

All 23 compounds for skin & connective tissue

Sources: National Center for Biotechnology Information 2026, PubChem compound summary for CID 90479646, tripeptide-10 citrulline; European Commission 2026, CosIng: Tripeptide-10 citrulline; Puig 2008, International Journal of Cosmetic Science, 30; Raikou 2017, Journal of Cosmetic Dermatology, 16; Errante 2020, Frontiers in Chemistry, 8; Bjerke 2026, Current Research in Toxicology, 10; U.S. Food and Drug Administration 2025, FDA authority over cosmetics: How cosmetics are not FDA-approved, but are FDA-regulated; U.S. Food and Drug Administration 2024, Is it a cosmetic, a drug, or both? (Or is it soap?); Kozlowski 2026, How FDA is implementing landmark cosmetics legislation to positively impact public health; U.S. Food and Drug Administration 2026, Modernization of Cosmetics Regulation Act of 2022 (MoCRA). All 10 citations

Back to the research library

References

  1. National Center for Biotechnology Information. (2026). PubChem compound summary for CID 90479646, tripeptide-10 citrulline. Retrieved November 17, 2026, from https://pubchem.ncbi.nlm.nih.gov/compound/90479646
  2. European Commission. (2026). CosIng: Tripeptide-10 citrulline (substance ID 83256). Retrieved November 17, 2026, from https://ec.europa.eu/growth/tools-databases/cosing/details/83256
  3. Puig, A., Antón, J. M., & Mangues, M. (2008). A new decorin-like tetrapeptide for optimal organization of collagen fibres. International Journal of Cosmetic Science, 30(2), 97-104. https://doi.org/10.1111/j.1468-2494.2008.00429.x
  4. Raikou, V., Varvaresou, A., Panderi, I., & Papageorgiou, E. (2017). The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3. A prospective, randomized controlled study. Journal of Cosmetic Dermatology, 16(2), 271-278. https://doi.org/10.1111/jocd.12314
  5. Errante, F., et al. (2020). Cosmeceutical peptides in the framework of sustainable wellness economy. Frontiers in Chemistry, 8, 572923. https://doi.org/10.3389/fchem.2020.572923
  6. Bjerke, D. L., et al. (2026). A framework for the safety evaluation of peptides in cosmetics. Current Research in Toxicology, 10, 100291. https://doi.org/10.1016/j.crtox.2026.100291
  7. U.S. Food and Drug Administration. (2025). FDA authority over cosmetics: How cosmetics are not FDA-approved, but are FDA-regulated (content current as of 11/18/2025). Retrieved November 17, 2026, from https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approved-are-fda-regulated
  8. U.S. Food and Drug Administration. (2024). Is it a cosmetic, a drug, or both? (Or is it soap?) (content current as of 09/11/2024). Retrieved November 17, 2026, from https://www.fda.gov/cosmetics/cosmetics-laws-regulations/it-cosmetic-drug-or-both-or-it-soap
  9. Kozlowski, S. (2026). How FDA is implementing landmark cosmetics legislation to positively impact public health. FDA Voices, U.S. Food and Drug Administration. Retrieved November 17, 2026, from https://www.fda.gov/news-events/fda-voices/how-fda-implementing-landmark-cosmetics-legislation-positively-impact-public-health
  10. U.S. Food and Drug Administration. (2026). Modernization of Cosmetics Regulation Act of 2022 (MoCRA) (content current as of 10/29/2026). Retrieved November 17, 2026, from https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra